1
2
Nov. 20, 2020 —The measles-mumps-rubella (MMR) vaccine has been theorized to provide protection against COVID-19. In a new study, researchers provide further proof of this by showing that mumps IgG titers, or ...
July 27, 2022 —New research has advanced COVID-19 vaccine work in several ways: using a modified live attenuated mumps virus for delivery, showing that a more stable coronavirus spike protein stimulates a stronger ...
Sep. 13, 2022 —Current vaccination strategies are unlikely to eliminate measles, according to a new study. The paper explores the feasibility of eliminating measles and rubella using predominant vaccination ...
Dec. 17, 2020 —Researchers evaluated changes in measles vaccination rates from before the pandemic to this summer, when return for clinical care was encouraged. Finding a steep and lasting decline, the researchers ...
Nov. 16, 2020 —Major measles outbreaks will likely occur during 2021 as an unexpected consequence of the COVID-19 pandemic, according to a new academic ...
Aug. 31, 2021 —Laboratory and retrospective analyses suggest that MMR and Tdap memory T cells are activated by SARS-CoV-2 and decrease COVID-19 ...
Jan. 11, 2023 —Vaccines that provide long-lasting protection against influenza, coronaviruses and respiratory syncytial virus (RSV) have proved exceptionally difficult to develop. Researchers now explore the ...
Apr. 29, 2021 —More than a quarter of American infants in 2018 had not received common childhood vaccines that protect them from illnesses such as polio, tetanus, measles, mumps and chicken pox, new research ...
Jan. 21, 2021 —Researchers have developed a new integrated genetic/epigenetic DNA-sequencing protocol known as MultiMMR that can identify the presence and cause of mismatch repair (MMR) deficiency in a single test ...
Feb. 3, 2021 —An experimental single-dose, intranasal influenza vaccine was safe and produced a durable immune response when tested in a Phase 1 study. The investigational vaccine, called Ad4-H5-VTN, is a ...